Although migraine is a disabling neurological condition that causes important disability, it remains an area of underdiagnosis and undertreatment worldwide. The aim of this study was to depict the burden of the unmet medical needs in migraine treated with triptans in a large Italian population.
Piccinni C., Cevoli S., Ronconi G., Dondi L., Calabria S., Pedrini A., et al. (2019). A real-world study on unmet medical needs in triptan-treated migraine: Prevalence, preventive therapies and triptan use modification from a large Italian population along two years. THE JOURNAL OF HEADACHE AND PAIN, 20, 1-9 [10.1186/s10194-019-1027-7].
A real-world study on unmet medical needs in triptan-treated migraine: Prevalence, preventive therapies and triptan use modification from a large Italian population along two years
Piccinni C.;Cevoli S.;Favoni V.;Pierangeli G.;Cortelli P.;
2019
Abstract
Although migraine is a disabling neurological condition that causes important disability, it remains an area of underdiagnosis and undertreatment worldwide. The aim of this study was to depict the burden of the unmet medical needs in migraine treated with triptans in a large Italian population.| File | Dimensione | Formato | |
|---|---|---|---|
|
A real-world study on unmet medical needs in triptan-treated migraine.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
737.7 kB
Formato
Adobe PDF
|
737.7 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
